Seven Years of Mini-Gastric Bypass in Type II Diabetes Patients with a Body Mass Index &lt;35&#160;kg/m(2). (Q40422710)

20 September 2017

Seven Years of Mini-Gastric Bypass in Type II Diabetes Patients with a Body Mass Index <35 kg/m(2). (English)

1 reference

20 September 2017

0 references

Kuldeepak S Kular

1

1 reference

20 September 2017

Naveen Manchanda

series ordinal

2

1 reference

20 September 2017

Gurpreet K Cheema

series ordinal

3

1 reference

20 September 2017

16 October 2015

1 reference

20 September 2017

1 reference

20 September 2017

26

1 reference

20 September 2017

1457-1462

1 reference

20 September 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1007/s11695-015-1941-y

20 September 2017

0 references

cites work

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Metabolic/bariatric surgery Worldwide 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Improvement in comorbid illness after placement of the Swedish Adjustable Gastric Band

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Efficacy of Laparoscopic Mini Gastric Bypass for Obesity and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with One Anastomosis Gastric Bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Bariatric surgery: Asia-Pacific perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

How do we define cure of diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Gastric bypass in the treatment of type 2 diabetes in patients with a BMI of 30 to 35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Short-term outcomes of laparoscopic single anastomosis gastric bypass (LSAGB) for the treatment of type 2 diabetes in lower BMI (<30 kg/m(2)) patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Laparoscopic mini-gastric bypass: experience with tailored bypass limb according to body weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI<30 kg/m2 (LBMI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Laparoscopic Roux-en-Y gastric bypass for BMI < 35 kg/m(2): a tailored approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Impact of bariatric surgery on cardiovascular and musculoskeletal morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Renal failure, glomerulonephritis and morbid obesity: improvement after rapid weight loss following laparoscopic gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

IFSO-APC consensus statements 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1941-Y

International Diabetes Federation position statement on bariatric surgery for type 2 diabetes: implications for patients, physicians, and surgeons

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26475028

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The medical risks of obesity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26475028

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11695-015-1941-Y

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference